TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 25 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,912 | -1.3% | 87,945 | +37.5% | 0.00% | – |
| Q2 2023 | $41,449 | -21.8% | 63,965 | 0.0% | 0.00% | – |
| Q1 2023 | $52,975 | +105850.0% | 63,965 | 0.0% | 0.00% | – |
| Q4 2022 | $50 | -99.9% | 63,965 | -0.2% | 0.00% | – |
| Q3 2022 | $69,000 | +102.9% | 64,092 | +2.8% | 0.00% | – |
| Q2 2022 | $34,000 | -32.0% | 62,353 | +17.5% | 0.00% | – |
| Q1 2022 | $50,000 | -7.4% | 53,053 | 0.0% | 0.00% | – |
| Q4 2021 | $54,000 | -45.5% | 53,053 | -0.1% | 0.00% | – |
| Q3 2021 | $99,000 | -28.3% | 53,097 | 0.0% | 0.00% | – |
| Q2 2021 | $138,000 | +31.4% | 53,097 | +49.5% | 0.00% | – |
| Q1 2021 | $105,000 | -9.5% | 35,515 | +0.0% | 0.00% | – |
| Q4 2020 | $116,000 | – | 35,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newbridge Financial Services Group, Inc. | 2 | $1 | 0.00% |
| Westside Investment Management, Inc. | 4 | $2 | 0.00% |
| Global Wealth Strategies & Associates | 40 | $19 | 0.00% |
| Cape Investment Advisory, Inc. | 1 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 157 | $73 | 0.00% |
| Nemes Rush Group LLC | 1 | $1 | 0.00% |
| Renaissance Technologies | 135,710 | $64 | 0.00% |
| VANGUARD GROUP INC | 82,051 | $38,892 | 0.00% |
| UBS Group AG | 4 | $2 | 0.00% |
| OSAIC HOLDINGS, INC. | 50 | $22 | 0.00% |